Pupil Bio
Houston, US · Founded 2022 · Delaware corporation
Pupil.bio is a biotechnology company developing molecular diagnostics, with a focus on cancer detection and related genomic assay technologies. Its team's background centers on liquid biopsy and cancer panel development.
Founders & leadership
BW
Bonnie WangNamed on SEC filing
DZ
David ZhangExecutive Chairman/Founder
Reported raises · per SEC filings
Form D private placements$500K disclosed across 1 round · 2023
▶$500KraisedMay 2023 · 3 investors · BiotechnologyRule 506(b)
▶$500KraisedMay 2023 · 3 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Bonnie WangExecutive Officer
- David ZhangExecutive Officer, Director
- Offering amount
- $2M
- Amount sold
- $500K
- First sale
- May 2023
- Incorporated
- Corporation, Delaware, 2022
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does Pupil Bio do?
- Pupil.bio is a biotechnology company developing molecular diagnostics, with a focus on cancer detection and related genomic assay technologies. Its team's background centers on liquid biopsy and cancer panel development.
- How much funding has Pupil Bio raised?
- Pupil Bio has disclosed $500K raised across 1 round.
- Where is Pupil Bio headquartered?
- Pupil Bio is headquartered in Houston, US.